Mindfulness + tDCS to Reduce Urgency Incontinence in Women

Sponsor
Cynthia Conklin (Other)
Overall Status
Recruiting
CT.gov ID
NCT04652869
Collaborator
National Institute on Aging (NIA) (NIH)
60
1
3
16.4
3.7

Study Details

Study Description

Brief Summary

Urge urinary incontinence (UUI) is a common problem in older women, which vastly reduces quality of life. UUI sufferers frequently report situational triggers (e.g. approaching the front door) leading to urinary urgency and/or leakage, which can be caused by psychological conditioning. This project will test the feasibility, acceptability, and efficacy of brief mindfulness (MI) and non-invasive brain stimulation (transcranial direct current stimulation; tDCS) to reduce reactivity to personal urgency cues and attenuate symptoms of UUI. This is a novel step towards providing personalized efficacious non-pharmacologic treatment for UUI.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial direct current stimulation
  • Behavioral: Mindfulness
N/A

Detailed Description

Urinary urgency incontinence (UUI) is a highly prevalent, morbid and costly (up to $83 billion/year) disorder among older women, with up to 36% of those over 65 afflicted. One commonly experienced phenomenon among those with UUI is conditioned bladder responses to external triggers, often labeled "situational incontinence." Situational incontinence is described by sufferers as urinary urgency and leakage when confronted with specific contextual triggers or cues, such as approaching the front/garage door 'latch-key incontinence', and exposure to running water such as doing dishes. Generally ascribed to 'bladder spasms' (detrusor overactivity), studies have revealed that anywhere between 42% and 80% of women with UUI experience situationally provoked urgency, with approximately 26% of those experiencing situationally triggered leakage. The researchers recent work has focused on developing methods to recreate exposure to individuals' situational urgency cues, testing the impact of "urgency" and "safe" cues on self-report urgency and actual leakage, and finally assessing the role of bladder control mechanisms in the brain in response to these personal situational cues. The researchers found that women with situational UUI experienced increased urgency and leakage when exposed to personal "urgency" versus "safe" photographic cues from their daily lives. Further, brain areas related to attentional and visuospatial processing were activated during exposure to urge, but not safe, cues. Past studies of urgency simulated by bladder filling, show that prefrontal cortex, a seat of executive control, is activated to aid in controlling bladder activation. However, the study found that the PFC was not recruited during exposure to visual cues among women with situational urgency. Thus, the researchers propose that interventions capable of enhancing PFC activation during exposure to urgency situations should enable women to gain executive control over cues and result in less cue-provoked urgency and leakage, as well as overall UUI symptomatology. Using these now well-tested methods to personalize stimuli with photographs of urgency-provoking situational cues, the goal is to test the feasibility, acceptability, and compliance of these promising methods to attenuate urgency-related reactivity and reduce UUI symptoms. These novel methods include: (1) Brief mindfulness (MI) focused on body scan and acceptance language, (2) Transcranial direct current stimulation (tDCS) applied to the dorsolateral PFC, and (3) a combination of MI + tDCS. Sixty women with situational UUI will be randomized into a 7-session study, with a mail-in follow up 1-week post-training. All participants will undergo 4 urgency-cue exposure training sessions during which they will engage in one of the three interventions, based on group. Changes in urgency will be assessed via pre-post training differences in: Cue-reactivity to personal urge and safe cues, reaction time to a urinary Stroop task, self-report severity of bladder problems, and UUI episodes and urgency ratings on a daily bladder diary. Attenuating reactivity to situational urgency cues will increase our ability to complement and enhance the efficacy of UUI therapy and reduce symptom burden for its many sufferers.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mindfulness + tDCS to Reduce Urgency Incontinence in Women
Actual Study Start Date :
May 21, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness Training

Mindfulness training

Behavioral: Mindfulness
Mindfulness is a type of meditation in which you focus on being intensely aware of what you're sensing and feeling in the moment, without interpretation or judgment.

Experimental: Transcranial Direct Current Stimulation (tDCS)

Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex

Device: Transcranial direct current stimulation
Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex
Other Names:
  • tDCS
  • Experimental: Mindfulness + tDCS

    Mindfulness training with transcranial direct current stimulation targeting the dorsolateral prefrontal cortex

    Device: Transcranial direct current stimulation
    Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex
    Other Names:
  • tDCS
  • Behavioral: Mindfulness
    Mindfulness is a type of meditation in which you focus on being intensely aware of what you're sensing and feeling in the moment, without interpretation or judgment.

    Outcome Measures

    Primary Outcome Measures

    1. Feasibility of study procedures measured by percentage of enrolled participants who complete the study [4-weeks]

    2. Acceptability of study procedures measured by 8-item with a 0-100 scale on the Post-Study Survey. A higher score indicates greater acceptability. [4-weeks]

    3. Compliance with study procedures measured by 2-items with a 0-100 scale on the Post-Study Survey. A higher score indicates greater compliance [4-weeks]

    4. Change from baseline in cue-induced reactivity to personal photographic urge cues as measured by a 8-item 0-100 scale questionnaire. A higher score indicates greater cue-reactivity [Baseline to 1 week]

    5. Reaction time to Urinary Stroop Task [Baseline to 1 week]

      Change in reaction time to words associated with urgency

    6. Change from baseline in severity of bladder problem measured by the ICIQ-FLUTS a 12-item questionnaire evaluating urinary tract symptoms and impact on quality of life. A higher score indicates greater symptoms and greater impact on quality of life. [Baseline to 1 week]

    7. Urge Urinary Incontinence (UUI) Incidence [Baseline to 1 week]

      Change in the number of UUI Incidences

    Secondary Outcome Measures

    1. Treatment Change [4 weeks]

      Treatment change will be examined by plotting the slope and linearity of daily bladder diary and urgency survey data

    2. Individual Differences as measured by age, years of UUI and baseline measures as moderators of the efficacy of the intervention [4 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female; 40+ years old

    • Self-report situational urgency in at least 4 of 15 common scenarios

    • At least 2 leaks/week

    • Urge Urinary Incontinence symptomatology bother score ≥4

    Exclusion Criteria:
    • Cognitive impairment (inability to complete tasks) as measured by an MoCA < 26

    • Urinary retention (PVR>200ml)

    • Interstitial cystitis

    • Spinal cord injury

    • Pelvic irradiation or other cause of pelvic nerve damage

    • Active urinary tract infection (UTI)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pittsburgh Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • Cynthia Conklin
    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Cynthia Conklin, PhD, University of Pittsburgh
    • Principal Investigator: Becky Clarkson, PhD, University of Pittsburgh

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cynthia Conklin, Associate Professor, University of Pittsburgh
    ClinicalTrials.gov Identifier:
    NCT04652869
    Other Study ID Numbers:
    • STUDY19110132
    • 1R21AG064361
    First Posted:
    Dec 3, 2020
    Last Update Posted:
    May 17, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Cynthia Conklin, Associate Professor, University of Pittsburgh
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 17, 2022